X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (226) 226
Patent (25) 25
Publication (20) 20
Conference Proceeding (14) 14
Newspaper Article (11) 11
Book / eBook (9) 9
Book Review (5) 5
Book Chapter (4) 4
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (64) 64
humans (45) 45
female (31) 31
male (29) 29
oncology (28) 28
adult (26) 26
middle aged (25) 25
analysis (23) 23
aged (20) 20
electricity (19) 19
cancer (17) 17
poland (17) 17
carcinoma, renal cell - drug therapy (14) 14
kidney neoplasms - drug therapy (14) 14
aged, 80 and over (12) 12
chemotherapy (12) 12
drug therapy (12) 12
kidney neoplasms - pathology (12) 12
young adult (12) 12
carcinoma, renal cell (11) 11
care and treatment (11) 11
medicine (11) 11
relays (11) 11
basic electric elements (10) 10
electric switches (10) 10
emergency protective devices (10) 10
selectors (10) 10
sunitinib (10) 10
electric communication technique (9) 9
mathematics (9) 9
medicine, general & internal (9) 9
multidisciplinary sciences (9) 9
quality of life (9) 9
sorafenib (9) 9
transmission of digital information, e.g. telegraphiccommunication (9) 9
treatment outcome (9) 9
abridged index medicus (8) 8
antineoplastic agents - therapeutic use (8) 8
clinical trials (8) 8
disease-free survival (8) 8
kaplan-meier estimate (8) 8
kidney neoplasms - mortality (8) 8
model (8) 8
patients (8) 8
research (8) 8
animals (7) 7
antineoplastic agents (7) 7
carcinoma, renal cell - mortality (7) 7
carcinoma, renal cell - secondary (7) 7
condensed matter (7) 7
double-blind (7) 7
kidney cancer (7) 7
life sciences (7) 7
metastasis (7) 7
risk factors (7) 7
science (7) 7
therapy (7) 7
toxicity (7) 7
vascular endothelial growth factor (7) 7
adolescent (6) 6
antimitotic agents (6) 6
antineoplastic agents - adverse effects (6) 6
article (6) 6
breast cancer (6) 6
carcinoma (6) 6
environmental sciences (6) 6
interferon-alpha (6) 6
locomotives (6) 6
management (6) 6
motor railcars (6) 6
neoplasm metastasis (6) 6
oceanography (6) 6
performing operations (6) 6
proportional hazards models (6) 6
proteins (6) 6
railways (6) 6
research article (6) 6
survival (6) 6
survival analysis (6) 6
transporting (6) 6
trial (6) 6
tumors (6) 6
calculating (5) 5
clinical medicine (5) 5
comparative analysis (5) 5
computing (5) 5
counting (5) 5
double-blind method (5) 5
efficacy (5) 5
electric digital data processing (5) 5
endothelial growth-factor (5) 5
expression (5) 5
gene expression (5) 5
geometry (5) 5
health aspects (5) 5
indoles - adverse effects (5) 5
physics (5) 5
physics, condensed matter (5) 5
plasma (5) 5
prognosis (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9807, pp. 1931 - 1939
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 6, pp. 552 - 562
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 6/2012, Volume 109, Issue 25, pp. 10119 - 10124
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2016, Volume 375, Issue 23, pp. 2246 - 2254
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2009, Volume 27, Issue 22, pp. 3584 - 3590
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2010, Volume 28, Issue 20, pp. 3239 - 3247
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2007, Volume 356, Issue 22, pp. 2271 - 2281
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2013, Volume 31, Issue 30, pp. 3791 - 3799
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2007, Volume 356, Issue 2, pp. 115 - 124
Sunitinib is one of several new antiangiogenic agents undergoing tests of efficacy in the treatment of various types of cancer. Renal-cell carcinoma of the... 
PHASE-III TRIAL | MEDICINE, GENERAL & INTERNAL | FUNCTIONAL ASSESSMENT | DOSE RECOMBINANT INTERLEUKIN-2 | CLINICAL-TRIALS | IN-VIVO | TUMOR-SUPPRESSOR GENE | TYROSINE KINASE INHIBITOR | RANDOMIZED-TRIAL | FACTOR RECEPTOR | ENDOTHELIAL GROWTH-FACTOR | Humans | Middle Aged | Male | Protein Kinase Inhibitors - adverse effects | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Pyrroles - adverse effects | Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors | Adult | Female | Carcinoma, Renal Cell - drug therapy | Pyrroles - therapeutic use | Angiogenesis Inhibitors - adverse effects | Receptors, Platelet-Derived Growth Factor - antagonists & inhibitors | Risk Factors | Interferon-alpha - therapeutic use | Kaplan-Meier Estimate | Kidney Neoplasms - mortality | Disease Progression | Carcinoma, Renal Cell - mortality | Indoles - adverse effects | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Renal Cell - secondary | Quality of Life | Indoles - therapeutic use | Kidney Neoplasms - pathology | Aged | Interferon-alpha - adverse effects | Kidney Neoplasms - drug therapy | Carcinoma, Renal cell | Comparative analysis | Drug therapy | Interferon alpha | Clinical trials | Interferon | Cytokines | Vascular endothelial growth factor | Skin cancer | Index Medicus | Abridged Index Medicus
Journal Article